专利改革法案很糟糕。
Patent reform acts ugly.
出版信息
Nat Biotechnol. 2007 Nov;25(11):1187. doi: 10.1038/nbt1107-1187.
PMID:17989652
Abstract
Controversial US patent system reforms and rule changes currently being proposed spell big trouble for biotech.
摘要
美国目前正在提议的有争议的专利制度改革和规则变更给生物技术行业带来了巨大麻烦。
相似文献
1
Patent reform acts ugly.专利改革法案很糟糕。
Nat Biotechnol. 2007 Nov;25(11):1187. doi: 10.1038/nbt1107-1187.
2
Patent first, ask questions later: morality and biotechnology in patent law.先申请专利，后提出问题：专利法中的道德与生物技术
William Mary Law Rev. 2003 Dec;45(2):469-547.
3
Recent US patent legislation: what's new for biotech?美国近期的专利立法：对生物技术领域而言有哪些新变化？
Nat Biotechnol. 2000 Feb;18(2):229-31. doi: 10.1038/72702.
4
Proposed changes to patent code loom over biotech industry.专利法的拟议修改给生物技术产业带来了威胁。
Nat Biotechnol. 2007 Dec;25(12):1333-4. doi: 10.1038/nbt1207-1333.
5
EU states back biotech patent reforms.欧盟各国支持生物技术专利改革。
Nature. 1993;366(6457):713. doi: 10.1038/366713a0.
6
US court bolsters biotech patent protection.
Nat Biotechnol. 2011 Aug 5;29(8):672-3. doi: 10.1038/nbt0811-672c.
7
US to rule on research patent.美国将对研究专利作出裁决。
Nature. 2006 Mar 30;440(7084):587. doi: 10.1038/440587a.
8
Biotech patents: the world is your oyster--or mouse--or (you name it).
Technol Health Care. 1996 Sep;4(3):255-8.
9
Supreme Court boosts licensees in biotech patent battles.最高法院在生物技术专利纠纷中支持被许可方。
Nat Biotechnol. 2007 Mar;25(3):264-5. doi: 10.1038/nbt0307-264. Epub 2007 Mar 1.
10
Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.知识产权。关于核因子κB专利的决定可能对生物技术产生广泛影响。
Science. 2006 May 12;312(5775):827. doi: 10.1126/science.312.5775.827a.
Zotero 插件